Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the final patient has been …